The Medicines Co (MDCO) Acquires Targanta Therapeutics (TARG) For $2/Share
Up)
The Medicines Company (Nasdaq: MDCO) entered into a merger agreement with Targanta Therapeutics Corporation (Nasdaq: TARG).
Under the terms of the merger agreement, Targanta shareholders will receive $2.00 in cash up front for each common share tendered, or approximately $42 million. Targanta shareholders may also be entitled to receive additional contingent cash payments upon the achievement of specified regulatory and commercial milestones within agreed upon time periods.
Shares of Targanta Therapeutics closed at $1.16 yesterday.
Under the terms of the merger agreement, Targanta shareholders will receive $2.00 in cash up front for each common share tendered, or approximately $42 million. Targanta shareholders may also be entitled to receive additional contingent cash payments upon the achievement of specified regulatory and commercial milestones within agreed upon time periods.
Shares of Targanta Therapeutics closed at $1.16 yesterday.
You May Also Be Interested In
- UPDATE: RR Donnelley (RRD) to Buy Edgar Online (EDGR) for $70.5M
- KKR (KKR) Said to Be in Talks with Delek Group for Phoenix Holdings Stake
- General Electric (GE) Makes $300M Investment in Large Brazilian Conglomerate
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
